Clinical Trial Update: Safety Study of GBS Following Menactra Meningococcal Vaccination

View source ↗

Summary

A completed clinical trial evaluating the safety of Guillain-Barré syndrome following Menactra meningococcal vaccination.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Guillain-barré Syndrome

Drugs mentioned

• Menactra (Meningococcal conjugate vaccine (A, C, W, Y))

Snippet

Sponsor: Harvard Pilgrim Health Care | Conditions: Guillain-Barre Syndrome | Status: COMPLETED